Does Borrelia burgdorferi IgG indicate established immune recognition rather than acute bloodstream infection?

In a 69-year-old man, these laboratory findings should be interpreted as markers of immune history and test performance—not as direct evidence of circulating Borrelia burgdorferi.

Serologic evidence

• B. burgdorferi–specific IgG reactivity indicates that adaptive immunity has recognized Borrelia antigens. Its clinical meaning depends on use of a validated standard or modified two-tier algorithm and on the specific antigen(s) detected.
• IgG alone does not demonstrate active Lyme disease, ongoing infection, treatment failure, or explain current symptoms. Borrelia-specific IgG may remain detectable for years or decades after infection has been eradicated and should not be used to monitor treatment response.
• Isolated antigen reactivity is especially limited: p41/flagellin is prone to cross-reactivity, and BmpA/p39 can cross-react with antibodies associated with other infections or rheumatoid factor. VlsE/C6 targets are more informative when interpreted within validated multistep testing.

Early-infection and blood-PCR interpretation

• Absent IgM cannot establish spirochetemia or otherwise determine whether acute infection is present. IgM commonly becomes detectable about 2–4 weeks after symptom onset, while antibodies can be absent for days to weeks after infection.
• This diagnostic window is clinically meaningful: standard two-tier serology has reported sensitivity of only 14% within one week of a solitary erythema migrans lesion.
• A negative blood PCR likewise does not demonstrate bloodstream infection and cannot reliably exclude early Lyme disease. Reported blood-PCR sensitivity ranges from 33.8% in plasma to 62% with a multilocus blood assay; in untreated solitary erythema migrans, sensitivity is often 30–50% or lower, consistent with transient low-level circulation and tissue localization.

Bottom line

• IgG reactivity supports established immune recognition, whereas absent IgM and negative blood PCR are nonconfirmatory results that neither prove spirochetemia nor reliably rule out early infection; clinical presentation, exposure timing, and appropriately timed follow-up serology remain decisive.